Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-725-8418
Summary
- Dr. Joy Wu is an endocrinologist in Stanford, CA and is affiliated with Stanford Health Care and VA Palo Alto Health Care System. She received her medical degree from Duke University School of Medicine and has been in practice 16 years. She specializes in osteoporosis & bone metabolism medicine and is experienced in osteoporosis and calcium and bone metabolism.
Education & Training
- Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2003 - 2006
- Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2003
- Duke University School of MedicineClass of 2001
Certifications & Licensure
- CA State Medical License 2012 - 2026
- MA State Medical License 2003 - 2013
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 109 citationsWnt Activation and Reduced Cell-Cell Contact Synergistically Induce Massive Expansion of Functional Human iPSC-Derived CardiomyocytesJan W. Buikema, Soah Lee, William R. Goodyer, Renee G.C. Maas, Orlando Chirikian
Cell Stem Cell. 2020-07-02 - 18 citationsTeriparatide (PTH 1-34) treatment increases peripheral hematopoietic stem cells in postmenopausal women.Elaine W. Yu, Ruchit Kumbhani, Erica Siwila-Sackman, Michelle E. DeLelys, Frederic I. Preffer
Journal of Bone and Mineral Research. 2014-06-01 - 44 citationsWoven bone overview: structural classification based on its integral role in developmental, repair and pathological bone formation throughout vertebrate groups.Frederic Shapiro, Joy Y. Wu
European Cells & Materials. 2019-10-01
Lectures
- PTH/PTHrP and CaSR SignalingENDO 2019 - New Orleans, LA - 3/26/2019
- Year in Osteoporosis Healthcare DeliveryENDO 2019 - New Orleans, LA - 3/23/2019
- Novel Uses of Parathyroid Hormone (PTH) and Parathyroid Hormone Related Protein (PTHrP)ENDO 2019 - New Orleans, LA - 3/26/2019
- Join now to see all
Press Mentions
- 5 Signs of OsteoporosisSeptember 16th, 2021
- National Shortages Threaten COVID-19 Response While Scientists Try to Get Needed ResourcesMarch 19th, 2020
- Shortage of RNA Extraction Kits Hampers Efforts to Ramp up COVID-19 Coronavirus TestingMarch 19th, 2020
Grant Support
- Role Of Gsalpha In Regulating Osteoblast DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2012
- "In Vivo Reconstitution Of The Hematopoietic Niche"Office Of The Director, National Institutes Of Health2011
- Sclerostin And Gsalpha Signaling In OsteoblastsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
- Role Of Gsalpha Signaling In OsteoblastsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: